ConductScience.org, home

Trial · NCT01586910

Results by group295

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
All-cause Mortality or Disabling Stroke Rate Expressed as a Posterior ProbabilityMedtronic CoreValve® System TAVI12.695% Confidence Interval 10.2 to 15.3Percentage of Participants
All-cause Mortality or Disabling Stroke Rate Expressed as a Posterior ProbabilitySAVR14.095% Confidence Interval 11.4 to 17.0Percentage of Participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)Medtronic CoreValve® System TAVI30 days5.7percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)SAVR30 days7.3percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)Medtronic CoreValve® System TAVI6 months9.5percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)SAVR6 months10.7percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)Medtronic CoreValve® System TAVI12 months13.0percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)SAVR12 months13.0percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)Medtronic CoreValve® System TAVI18 months15.6percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)SAVR18 months14.8percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)Medtronic CoreValve® System TAVI24 months18.5percentage of participants
Percentage of Participants With Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)SAVR24 months18.2percentage of participants
Percentage of Participants With Individual MACCE ComponentsMedtronic CoreValve® System TAVI30 day All Cause Mortality2.1percentage of participants
Percentage of Participants With Individual MACCE ComponentsSAVR30 day All Cause Mortality1.6percentage of participants
Percentage of Participants With Individual MACCE ComponentsMedtronic CoreValve® System TAVI30 day MI0.8percentage of participants
Percentage of Participants With Individual MACCE ComponentsSAVR30 day MI0.9percentage of participants
Percentage of Participants With Individual MACCE ComponentsMedtronic CoreValve® System TAVI30 day Stroke3.3percentage of participants
Percentage of Participants With Individual MACCE ComponentsSAVR30 day Stroke5.4percentage of participants
Percentage of Participants With Individual MACCE ComponentsMedtronic CoreValve® System TAVI30 day Reintervention0.8percentage of participants
Percentage of Participants With Individual MACCE ComponentsSAVR30 day Reintervention0.1percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01586910/results